Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
TP regimen
Description:
A chemotherapy regimen combining a taxane, usually paclitaxel, with a platinum-based drug to treat cancer.
Primary topic:
Head and Neck Cancer Studies (23%)
Related topics:
Head and Neck Cancer Studies (23%),
Lung Cancer Diagnosis and Treatment (20%),
Endometrial and Cervical Cancer Treatments (9%),
Ovarian cancer diagnosis and treatment (9%),
Esophageal Cancer Research and Treatment (9%)
OpenAlex ID:
keywords/tp-regimen
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study
2009
·
A.A. Lissoni
, N. Colombo
, et al.
·
Annals of Oncology
·
129
PDF
The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
2011
·
Mingzhu Yin
, Falin Zhao
, et al.
·
PubMed
·
84
Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
2013
·
Lingli Tu
, Lan Sun
, et al.
·
Radiation Oncology
·
41
PDF
Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysis
2018
·
Hao Peng
, Ling-Long Tang
, et al.
·
Oral Oncology
·
33
Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer
2014
·
Hongying Lv
, Ting Han
, et al.
·
Medical Oncology
·
33
Induction Chemotherapy in Locally Advanced Head and Neck Cancer: A New Standard of Care?
2008
·
Jochen H. Lorch
, Marshall R. Posner
, et al.
·
Hematology/Oncology Clinics of North America
·
30
Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature
2015
·
LI LIN
, CHUN-WEI XU
, et al.
·
Experimental and Therapeutic Medicine
·
29
PDF
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
2020
·
Sai-Lan Liu
, Xue-Song Sun
, et al.
·
BMC Cancer
·
26
PDF
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer
2024
·
Vanita Noronha
, Vijay Patil
, et al.
·
European Journal of Cancer
·
24
Which induction chemotherapy regimen followed by cisplatin-based concurrent chemoradiotherapy is the best choice among PF, TP and TPF for locoregionally advanced nasopharyngeal carcinoma?
2019
·
Yan He
, Tao Guo
, et al.
·
Annals of Translational Medicine
·
23
PDF
Clinical Study on Mannan Peptide Combined with TP Regimen in Treating Patients with Non-small Cell Lung Cancer
2013
·
Huai-An Yan
, Kang Shen
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
19
PDF
[Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
2007
·
Fang-Yun Xie
, Shu-Nan Qi
, et al.
·
PubMed
·
19
Adjuvant chemotherapy for early-stage cervical cancer
2016
·
Hiroshi Asano
, Yukiharu Todo
, et al.
·
Chinese Journal of Cancer Research
·
18
Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer
2010
·
Shun Wang
, Da-Shui Zhang
, et al.
·
癌症:英文版
·
18
PDF
Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced hypopharyngeal and laryngeal squamous cell carcinoma
2024
·
Jin Peng
, Guangfeng Luo
, et al.
·
Cancer Immunology Immunotherapy
·
17
PDF
A random study of xiaoaiping injection combined with chemotherapy on the treatment of advanced non-small cell lung cancer
2009
·
Mingyu Liu
·
Chinese Clinical Oncology
·
17
Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis
2024
·
Weilin Xu
, Lei Qiu
, et al.
·
Oral Oncology
·
12
Successful downstaging of locally recurrent penile squamous cell carcinoma with neoadjuvant nanosomal docetaxel lipid suspension (NDLS) based regimen followed by curative surgery
2017
·
Sameer Gupta
, Shashi Singh Pawar
, et al.
·
BMJ Case Reports
·
11
PDF
Comparison of TPF and TP Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma Based on TNM Stage and Pretreatment Systemic Immune-Inflammation Index
2021
·
Ying Xiong
, Liang liang Shi
, et al.
·
Frontiers in Oncology
·
10
PDF
Nomogram-aided individual induction chemotherapy regimen selection in advanced nasopharyngeal carcinoma
2021
·
Hao Peng
, Lei Chen
, et al.
·
Oral Oncology
·
9
Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
2012
·
M Moioli
, A Papadia
, et al.
·
PubMed
·
9
Role of adjuvant chemotherapy after pneumonectomy for non-small cell lung cancer
2012
·
MENG WANG
, JING ZHAO
, et al.
·
Oncology Letters
·
8
PDF
[Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
2009
·
Fang-Yun Xie
, Guo-Rong Zou
, et al.
·
PubMed
·
8
Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma
2023
·
Zhengfeng Zhang
, Lei Yang
, et al.
·
Therapeutic Advances in Medical Oncology
·
7
PDF
Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer
2017
·
Matthew A Hoch
, Kati Cousins
, et al.
·
Journal of Oncology Pharmacy Practice
·
7
Show more works
View as search
Works count:
346
Citation count:
803
Year
Topic
Type